Literature DB >> 20862477

Differential diagnosis and prognosis of T1-weighted post-gadolinium intralabyrinthine hyperintensities.

F Dubrulle1, R Kohler, C Vincent, P Puech, O Ernst.   

Abstract

OBJECTIVES: The aim of this longitudinal study is to describe the different intralabyrinthine lesions yielding high signal intensity on T1-weighted (T1W) images after intravenous gadolinium and then to analyze the follow-up of these patients.
METHODS: Thirty-seven patients were included and followed clinically and radiologically. A precise analysis of MR labyrinthine signals allowed exact depiction of the different lesions. Special interest is focused on the intralabyrinthine fluid signal on 3D high-resolution T2W images.
RESULTS: The enhanced T1W labyrinthine hyperintensities correspond to two different categories: intralabyrinthine enhancement (15 intralabyrinthine schwannomas, 13 labyrinthitis, 1 inflammatory granuloma) and spontaneous T1W hyperintensities (8 intralabyrinthine hemorrhages). Hemorrhagic lesions show a substantial decrease of the intralabyrinthine fluid signal on the 3D HRT2 that evolves to ossification. In labyrinthitis, the importance of the initial labyrinthine fluid signal decrease on the 3D HRT2 is well correlated with the hearing prognosis.
CONCLUSION: A meticulous analysis of inner ear lesions allows various intralabyrinthine lesions, in particular schwannomas, to be differentiated from labyrinthitis. T1W imaging without gadolinium is essential for the correct diagnosis of rapidly evolving hearing loss. In labyrinthitis and intralabyrinthine hemorrhage, 3D HRT2 brings an interesting prognostic factor for the chance of hearing recovery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862477     DOI: 10.1007/s00330-010-1835-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Intravestibular lipoma: an important imaging diagnosis.

Authors:  Meike W Vernooij; M Arfan Ikram; Arnaud J P E Vincent; Monique M B Breteler; Aad van der Lugt
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-11

2.  Clinical features of sudden hearing loss associated with a high signal in the labyrinth on unenhanced T1-weighted magnetic resonance imaging.

Authors:  S Shinohara; E Yamamoto; S Saiwai; J Tsuji; Y Muneta; M Tanabe; T Sakamoto; T Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2000-11       Impact factor: 2.503

3.  Diagnosis and management of intralabyrinthine schwannomas.

Authors:  J D Green; J D McKenzie
Journal:  Laryngoscope       Date:  1999-10       Impact factor: 3.325

4.  MR findings in intralabyrinthine schwannomas.

Authors:  Mary-Louise Montague; Ameet Kishore; Donald M Hadley; Brian F O'Reilly
Journal:  Clin Radiol       Date:  2002-05       Impact factor: 2.350

5.  [Labyrinthitis, or inflammatory pseudotumor after stapedectomy].

Authors:  C Pavillon-Maisonnier; F Faure; I Plouin-Gaudon; E Truy
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  2007-08-20

6.  Pathology of the membranous labyrinth: comparison of T1- and T2-weighted and gadolinium-enhanced spin-echo and 3DFT-CISS imaging.

Authors:  J W Casselman; R Kuhweide; W Ampe; L Meeus; L Steyaert
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

7.  Sensorineural hearing loss: more than meets the eye?

Authors:  A S Mark; S Seltzer; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

8.  Intralabyrinthine schwannomas: diagnosis, management, and a new classification system.

Authors:  Richard J Kennedy; Clough Shelton; Karen L Salzman; H Christian Davidson; H Ric Harnsberger
Journal:  Otol Neurotol       Date:  2004-03       Impact factor: 2.311

9.  MR imaging of intralabyrinthine schwannoma, labyrinthitis, and other labyrinthine pathology.

Authors:  M F Mafee
Journal:  Otolaryngol Clin North Am       Date:  1995-06       Impact factor: 3.346

10.  Intralabyrinthine schwannoma: subtle differentiating symptomatology.

Authors:  Lance E Jackson; Karen K Hoffmann; Seth I Rosenberg
Journal:  Otolaryngol Head Neck Surg       Date:  2003-10       Impact factor: 5.591

View more
  8 in total

1.  [Intralabyrinthine schwannoma from a radiological perspective].

Authors:  S Kösling
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

2.  [Inflammatory diseases of the petrous portion of the temporal bone].

Authors:  H Körner
Journal:  Radiologe       Date:  2014-04       Impact factor: 0.635

3.  Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2.

Authors:  S Withers; S K Plontke; R Boeddinghaus; J Kuthubutheen; M Atlas
Journal:  HNO       Date:  2020-01       Impact factor: 1.284

Review 4.  Meta-analysis on the clinical outcomes in patients with intralabyrinthine schwannomas: conservative management vs. microsurgery.

Authors:  Émilie Gosselin; Anastasios Maniakas; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

5.  Partial Recovery of Audiological, Vestibular, and Radiological Findings following Spontaneous Intralabyrinthine Haemorrhage.

Authors:  Thomas Pézier; Krisztina Baráth; Stefan Hegemann
Journal:  Case Rep Otolaryngol       Date:  2013-12-24

Review 6.  Post traumatic deafness: a pictorial review of CT and MRI findings.

Authors:  Olivier Maillot; Arnaud Attyé; Eric Boyer; Olivier Heck; Adrian Kastler; Sylvie Grand; Sébastien Schmerber; Alexandre Krainik
Journal:  Insights Imaging       Date:  2016-04-16

7.  Sudden sensorineural hearing loss associated with inner ear lesions detected by magnetic resonance imaging.

Authors:  Jiwon Cho; Hanjae Cheon; Jung Hye Park; Hyo-Jeong Lee; Hyung-Jong Kim; Hyo Geun Choi; Ja-Won Koo; Sung Kwang Hong
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

8.  Suppurative labyrinthitis associated with otitis media: 26 years' experience.

Authors:  André Souza de Albuquerque Maranhão; Valeria Romero Godofredo; Norma de Oliveira Penido
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.